October 25, 2019October 25, 2019

One-year Data Support Efficacy and Safety of Abivax’s ABX464 for Ulcerative Colitis

News

Abivax has announced data from a long-term trial that continues to support the efficacy and safety of its investigational oral treatment ABX464 for ulcerative colitis (UC). One year of treatment ... Read more

June 17, 2019June 17, 2019

Nine-Month Results Show Continuing Efficacy of Abivax’s ABX464 in Extension Trial

News

Treatment with Abivax‘s ABX464 showed continuing effectiveness in ulcerative colitis patients, according to nine-month data of a maintenance clinical trial. The company is now recruiting people with moderate-to-severe ulcerative colitis ... Read more